Quantitators: Using model based drug development to effectively develop anti- malarial agents

• In: Symposium T1: Integrated Development of New Therapeutics for Global Health on Monday, 22 May 2017, 16:40-17:15
• At: Stockholm (Sweden) (2017)
• Type: Presentation
• By: KERN, Steven (Bill & Melinda Gates Foundation, Quantitative Sciences, Seattle, United States)
• Co-author(s): Steven Kern: Quantitative Sciences, Bill & Melinda Gates Foundation, Seattle, United States
  
• Abstract:

  Pharmacometric analysis has emerged as an important tool to improve the drug development process within the pharmaceutical industry.  These methods have not been fully exploited for drug development efforts that support global health indications such as malaria, tuberculosis, and neglected tropical diseases.  The Quantitative Sciences team at the

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login